Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognostic significance of telomerase reverse transcriptase promoter gen mutations in high grade meningiomas.
Cañas A, Jiménez E, Hakim F, Mejía JA, Ramón JF, Gómez D, Jaramillo-Velásquez D, Bermúdez S, Useche N, Pineda D, Cifuentes H, Becerra A, Muñoz Á, Santoyo N, Ruíz-Patiño A, Sotelo C, Archila P, Rodríguez J, Ávila J, Ordoñez-Reyes C, García-Robledo JE, Ricaurte L, Rojas L, Feo O, Burgos R, Ramírez C, Arrieta O, Zatarain-Barrón L, Vargas C, Carranza H, Otero J, Cardona AF. Cañas A, et al. Among authors: useche n. Biomedica. 2022 Dec 1;42(4):574-590. doi: 10.7705/biomedica.6100. Biomedica. 2022. PMID: 36511679 Free PMC article. English, Spanish.
Primary stroke prevention worldwide: translating evidence into action.
Owolabi MO, Thrift AG, Mahal A, Ishida M, Martins S, Johnson WD, Pandian J, Abd-Allah F, Yaria J, Phan HT, Roth G, Gall SL, Beare R, Phan TG, Mikulik R, Akinyemi RO, Norrving B, Brainin M, Feigin VL; Stroke Experts Collaboration Group. Owolabi MO, et al. Lancet Public Health. 2022 Jan;7(1):e74-e85. doi: 10.1016/S2468-2667(21)00230-9. Epub 2021 Oct 29. Lancet Public Health. 2022. PMID: 34756176 Free PMC article. Review.
Efficacy of osimertinib plus bevacizumab in glioblastoma patients with simultaneous EGFR amplification and EGFRvIII mutation.
Cardona AF, Jaramillo-Velásquez D, Ruiz-Patiño A, Polo C, Jiménez E, Hakim F, Gómez D, Ramón JF, Cifuentes H, Mejía JA, Salguero F, Ordoñez C, Muñoz Á, Bermúdez S, Useche N, Pineda D, Ricaurte L, Zatarain-Barrón ZL, Rodríguez J, Avila J, Rojas L, Jaller E, Sotelo C, Garcia-Robledo JE, Santoyo N, Rolfo C, Rosell R, Arrieta O. Cardona AF, et al. Among authors: useche n. J Neurooncol. 2021 Sep;154(3):353-364. doi: 10.1007/s11060-021-03834-3. Epub 2021 Sep 9. J Neurooncol. 2021. PMID: 34498213
Effect of a High-Intensity Tandem Bicycle Exercise Program on Clinical Severity, Functional Magnetic Resonance Imaging, and Plasma Biomarkers in Parkinson's Disease.
Segura C, Eraso M, Bonilla J, Mendivil CO, Santiago G, Useche N, Bernal-Pacheco O, Monsalve G, Sanchez L, Hernández E, Peláez-Jaramillo MJ, Cárdenas-Mojica A. Segura C, et al. Among authors: useche n. Front Neurol. 2020 Jul 24;11:656. doi: 10.3389/fneur.2020.00656. eCollection 2020. Front Neurol. 2020. PMID: 32793096 Free PMC article.
The Type and Amount of Dietary Fat Affect Plasma Factor VIIc, Fibrinogen, and PAI-1 in Healthy Individuals and Individuals at High Cardiovascular Disease Risk: 2 Randomized Controlled Trials.
Kris-Etherton PM, Stewart PW, Ginsberg HN, Tracy RP, Lefevre M, Elmer PJ, Berglund L, Ershow AG, Pearson TA, Ramakrishnan R, Holleran SF, Dennis BH, Champagne CM, Karmally W; DELTA Investigators. Kris-Etherton PM, et al. J Nutr. 2020 Aug 1;150(8):2089-2100. doi: 10.1093/jn/nxaa137. J Nutr. 2020. PMID: 32492148 Free PMC article. Clinical Trial.
Systemic management of malignant meningiomas: A comparative survival and molecular marker analysis between Octreotide in combination with Everolimus and Sunitinib.
Cardona AF, Ruiz-Patiño A, Zatarain-Barrón ZL, Hakim F, Jiménez E, Mejía JA, Ramón JF, Useche N, Bermúdez S, Pineda D, Cifuentes H, Rojas L, Ricaurte L, Pino LE, Balaña C, Arrieta O. Cardona AF, et al. Among authors: useche n. PLoS One. 2019 Jun 20;14(6):e0217340. doi: 10.1371/journal.pone.0217340. eCollection 2019. PLoS One. 2019. PMID: 31220093 Free PMC article. Clinical Trial.
A comprehensive analysis of factors related to carmustine/bevacizumab response in recurrent glioblastoma.
Cardona AF, Rojas L, Wills B, Ruiz-Patiño A, Abril L, Hakim F, Jiménez E, Useche N, Bermúdez S, Mejía JA, Ramón JF, Carranza H, Vargas C, Otero J, Archila P, Rodríguez J, Rodríguez J, Behaine J, González D, Jacobo J, Cifuentes H, Feo O, Penagos P, Pineda D, Ricaurte L, Pino LE, Vargas C, Marquez JC, Mantilla MI, Ortiz LD, Balaña C, Rosell R, Zatarain-Barrón ZL, Arrieta O. Cardona AF, et al. Among authors: useche n. Clin Transl Oncol. 2019 Oct;21(10):1364-1373. doi: 10.1007/s12094-019-02066-2. Epub 2019 Feb 23. Clin Transl Oncol. 2019. PMID: 30798512
18 results